Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ECOI has been making some noise around.They have recently put out news that it has a fully executed Letter of Intent with SolCool One, LLC, “SolCool”, a private solar company.The past week has been wonderful for this stock it was gone up over 300%, had lots of volume and continued to be successful as we head closer to Friday. I hope you have been keeping this on your radar for this week because we are starting to show big improvements and a more successful company as the new year continues.
ECOI HOT NEWS AFTER 33% Gain today,
Press Release Source: ecoSolutions Intl. On Monday January 10, 2011, 5:00 pm
ASHLAND, Ore.--(BUSINESS WIRE)-- ecoSolutions Intl. (Pink Sheets:ECOI.pk - News) announced today it has a fully executed Letter of Intent with SolCool One, LLC, “SolCool”, a private solar company.
SolCool has developed a direct current, solar air-conditioning unit for distribution to the communication and off-grid global markets. Systems are designed to substantially reduce energy costs while improving back-up power capability.
In October 2010 SolCool successfully sold a 6000 BTU system to Freeport McMoRan (NYSE:FCX - News), the largest publicly traded gold and copper producer in the world. Freeport McMoRan is utilizing the unit in a remote, off-grid location to cool equipment that monitors seismic activity.
“The future of energy management with large, power-consuming customers is growing exponentially, and SolCool is well positioned to market and sell its products directly into that segment,” ecoSolutions Intl. CEO Lawrence Adams stated. "The market for this and other SolCool energy products is growing exponentially as these types of companies turn to key vendors for Solar and off-grid solutions.”
SolCool is located in San Bernardino, CA. “We feel SolCool has a vast array of products ready for entry into this growing market demand, we look forward to a long and prosperous partnership,” Mr. Adams commented in closing.
ECOI HOT NEWS AFTER 33% Gain today,
Press Release Source: ecoSolutions Intl. On Monday January 10, 2011, 5:00 pm
ASHLAND, Ore.--(BUSINESS WIRE)-- ecoSolutions Intl. (Pink Sheets:ECOI.pk - News) announced today it has a fully executed Letter of Intent with SolCool One, LLC, “SolCool”, a private solar company.
SolCool has developed a direct current, solar air-conditioning unit for distribution to the communication and off-grid global markets. Systems are designed to substantially reduce energy costs while improving back-up power capability.
In October 2010 SolCool successfully sold a 6000 BTU system to Freeport McMoRan (NYSE:FCX - News), the largest publicly traded gold and copper producer in the world. Freeport McMoRan is utilizing the unit in a remote, off-grid location to cool equipment that monitors seismic activity.
“The future of energy management with large, power-consuming customers is growing exponentially, and SolCool is well positioned to market and sell its products directly into that segment,” ecoSolutions Intl. CEO Lawrence Adams stated. "The market for this and other SolCool energy products is growing exponentially as these types of companies turn to key vendors for Solar and off-grid solutions.”
SolCool is located in San Bernardino, CA. “We feel SolCool has a vast array of products ready for entry into this growing market demand, we look forward to a long and prosperous partnership,” Mr. Adams commented in closing.
ECOI great news This stock is the most undervalued under appreciated stock Ive seen around.I believe this stock is sitting at all time lows as of now I have never been so excited to buy a stock.This stock has recently came out with great news that will send this stock into the moon IMO The CEO has what it takes to make this stock into a serious money making machine.He has begun putting out more news to the investors to keep everyone more informed on the company and by the looks of it is showing a lot of improvement coming into 2011 i hope everyone keeps this stock in there sights and hopefully there portfolio.Here's the most recent PR this company has come out with enjoy
Press Release Source: EcoSolutions Intl. On Friday January 7, 2011, 10:06 am EST
ASHLAND, Ore.--(BUSINESS WIRE)-- EcoSolutions Intl. (Pink Sheets:ECOI.pk - News) The company announced today, it has executed an LOI for its first acquisition. The target company is in the Solar space, keeping with the initial business model of EcoSolutions Intl. The board has unanimously approved the terms and conditions of the LOI, and is awaiting execution from the counter party. "We are excited to begin the acquisition strategy mentioned in my initial Press Release," CEO Lawrence Adams stated. The company expects to receive back a fully executed LOI early next week, and will release details of the transaction at that point.
ECOI RADAR This stock has just started to come around and make some serious noise.This is a very undervalued under appreciated stock that IMO will be discovered very shortly but thankfully enough im here to shine light on this stock before it begins to run,And when i mean run i mean were looking at a stock that sitting on .03 cents is nothing compared to what i believe it can really show.I hope that everyone has this stock on there radar and hopefully soon in there portfolio.This CEO is starting to show investors that this stock can bring serious money into there pockets.There are many things to like about this stock and this is a stock that has shown me there aren't many flaws surrounding it,I must say that with this recent PR this company is looking like 2011 is their year.Im glad to be sitting here telling everyone first about this stock and hopefully by now you have thought to do your own research on this company and is as excited as i am about this. Please read below as the most recent PR has confirmed a GREAT buy IMO for this company to start showing investors some real money.
Press Release Source: EcoSolutions Intl. On Friday January 7, 2011, 10:06 am EST
ASHLAND, Ore.--(BUSINESS WIRE)-- EcoSolutions Intl. (Pink Sheets:ECOI.pk - News) The company announced today, it has executed an LOI for its first acquisition. The target company is in the Solar space, keeping with the initial business model of EcoSolutions Intl. The board has unanimously approved the terms and conditions of the LOI, and is awaiting execution from the counter party. "We are excited to begin the acquisition strategy mentioned in my initial Press Release," CEO Lawrence Adams stated. The company expects to receive back a fully executed LOI early next week, and will release details of the transaction at that point.
ECOI Is the stock that i believe is the most under priced and under valued of the year so far.Without a doubt i believe this stock has wha it takes to set forth new highs very shortly.This CEO has everything it takes to make this company a very profitable and successful stock.Ive never seen a stock with such high standards and positive feedback.Many people have yet to see what this stock has to offer i see this being one of the biggest picks of the year.I see Alot more PR's to come from this company and really give this stock a run for the money.Seeing this stock @ .03 is a steal i will be buying up many many shares of this stock.I believe that given its recent push in volume and great share structure this stock has just seen the beginning of whats to come. Feel free to read the bottom of my post and read the recent PR.I see many more to come from this company and this company to start giving more frequent PR's to ensure to the share holders this company is just at the start of many great things to come.
Press Release Source: EcoSolutions Intl. On Friday January 7, 2011, 10:06 am EST
ASHLAND, Ore.--(BUSINESS WIRE)-- EcoSolutions Intl. (Pink Sheets:ECOI.pk - News) The company announced today, it has executed an LOI for its first acquisition. The target company is in the Solar space, keeping with the initial business model of EcoSolutions Intl. The board has unanimously approved the terms and conditions of the LOI, and is awaiting execution from the counter party. "We are excited to begin the acquisition strategy mentioned in my initial Press Release," CEO Lawrence Adams stated. The company expects to receive back a fully executed LOI early next week, and will release details of the transaction at that point.
**ECOI** will have a great year.This stock has been put under the radar and is starting accumulate more buys in this stock.It came out with great news the last couple days and This CEO has what it takes to make this stock soar into all new highs. I see this stock right now actually sitting at lows.Keep this stock on your radar and hopefully in your portfolio because without a doubt this stock will be seeing a much higher price shortly.When you come out and actually look at this stock you can see its very under priced.Check the news out on this stock recently!
Press Release Source: EcoSolutions Intl. On Friday January 7, 2011, 10:06 am EST
ASHLAND, Ore.--(BUSINESS WIRE)-- EcoSolutions Intl. (Pink Sheets:ECOI.pk - News) The company announced today, it has executed an LOI for its first acquisition. The target company is in the Solar space, keeping with the initial business model of EcoSolutions Intl. The board has unanimously approved the terms and conditions of the LOI, and is awaiting execution from the counter party. "We are excited to begin the acquisition strategy mentioned in my initial Press Release," CEO Lawrence Adams stated. The company expects to receive back a fully executed LOI early next week, and will release details of the transaction at that point.
without a doubt i see this stock price doubling.This stock has recently come out with great news and it looks as tho we will see higher trending as the weeks progress.We should expect more PR's to be pushed out regularly this CEO is trying to make this stock more open to the public and has been coming up with new ways to make this stock have profits for everyone.I believe this is only the beginning,Expect this stock to reach all new highs now that we have the new year under way.Keep this stock in your sights and hopefully in your portfolio i can tell you now, You will not regret it. Press Release Source: EcoSolutions Intl. On Friday January 7, 2011, 10:06 am EST
ASHLAND, Ore.--(BUSINESS WIRE)-- EcoSolutions Intl. (Pink Sheets:ECOI.pk - News) The company announced today, it has executed an LOI for its first acquisition. The target company is in the Solar space, keeping with the initial business model of EcoSolutions Intl. The board has unanimously approved the terms and conditions of the LOI, and is awaiting execution from the counter party. "We are excited to begin the acquisition strategy mentioned in my initial Press Release," CEO Lawrence Adams stated. The company expects to receive back a fully executed LOI early next week, and will release details of the transaction at that point.
ECOF nearing 52-week low GREAT buy
Press Release Source: ECO2 Forests Inc. On Thursday December 9, 2010, 8:00 am EST
BOULDER, CO and QUEENSLAND, AUSTRALIA--(Marketwire - 12/09/10) - ECO2 Forests Inc. (Pinksheets:ECOF - News), a sustainable forestry company, has entered into an Agreement for the establishment of joint venture projects in Europe.
In conjunction with ECO PLUS Limited, ECO2 Forests plans to commence projects in Europe. Initially targeting projects in Turkey, the Joint Venture is planned to be expanded to include Bulgaria.
The two companies signed the Agreement to develop the mutually beneficial project that will create a significant amount of local full-time jobs as well as the injection of millions of dollars into the local economy.
Initially, the goal is to establish the first of the European projects with a 1,200 acre forest in the vicinity of Izmir, Turkey.
Under the agreement ECO2 Forests will be responsible for all aspects of managing and control of the Plantation which is forecast to involve the planting of 268,800 Kiri Trees to produce 537,600 carbon credits and 113,000 tons of lumber every seven year cycle. The Kiri Tree naturally regrows after each harvest to create a truly sustainable forest and decreases the need to log existing old growth forests. The initial part of the project is forecast to deliver returns of an estimated US$120 million in each seven year cycle.
"ECO2 Forests has been working extremely hard this year to establish a network of forests around the globe under our Global Forestry Plan. Strategically we had targeted the Izmir region in Turkey as our research indicated the land was suitable for our Kiri Tree forests. We look forward to working with ECO PLUS to initiate the first module in the project and secure more projects in the region," ECO2 Forests CEO Ray Smith said today.
ECO Plus will be responsible for sourcing all land for the projects and jointly with ECO2 Forests intends to source suitable project financing through direct project investment.
In accordance with the ECO2 Forests' E4 Philosophy, ECO2 Forests and ECO PLUS both have agreed to work collaboratively to develop and implement projects that provide a positive outcome for the environment, improve the well-being and circumstances of stakeholders in the local community and host country as well as enter into joint venture agreements that are deemed mutually beneficial for the delivery of programs and projects.
"ECO PLUS became aware of ECO2 Forests and their Global Forestry Plan many months ago and we were very excited to find a company that was capable of creating this type of sustainable project in our region of the world. We have been in regular communication from that point and it is a significant milestone to sign this agreement. We must plant as many trees as possible and we all need more people in the world involved in the fight against climate change," ECO PLUS Director Michael Ginchin said.
About ECO2 Forests Inc.
ECO2 Forests was created to deliver large scale sustainable, lumber-producing forests through an innovative E4 Philosophy -- embracing positive Environmental impact and delivering Economic returns, while fostering Employment and Education.
Company projects are operated under the Global Forestry Plan which calls for the creation of thousands of acres of new forests to be planted and maintained in key locations around the world.
A publicly traded company, ECO2 Forests trades under the U.S. Stock Symbol ECOF. With offices in Boulder, Colorado and Queensland, Australia, the company has been structured specifically to be positioned for global growth and support.
For more information please visit www.eco2forests.com.
Forward Looking Statements
This press release contains statements which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-looking statements include fluctuation of operating results, the ability to compete successfully, and the ability to complete before-mentioned transactions. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events, or changes to future operating results.
ILVC .Intelligent Living Joint Venture With First Nations Could Produce $40 Million in Revenues Within Five Years
Share
retweet
EmailPrint..Companies:INTELLIGENT LIVING.Related Quotes
Symbol Price Change
ILVC.OB 0.0125 0.00
{"s" : "ilvc.ob","k" : "a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00","o" : "","j" : ""} Press Release Source: Intelligent Living Corp. On Saturday December 4, 2010, 10:15 pm EST
VANCOUVER, BC--(Marketwire - 12/04/10) - Intelligent Living Corp. ("ILVC"), (OTC.BB:ILVC - News), a leading automation and technology solutions provider utilizing green building practices, is moving forward on a three part joint venture strategy that targets First Nations housing, small footprint new and re-developed housing within the Greater Vancouver market and export markets for small home technology. The joint venture strategy combines ILC's energy management and automation expertise with established First Nations domestic and offshore wood supply and small footprint home manufacturing to achieve target joint venture annual revenue of $40 million.
"Canadian Mortgage and Housing Corporation and National Aboriginal Housing Association have estimated the immediate sustainable demand for First Nations housing in British Columbia at over 20,000 units per year. Amendment of residential zoning with the greater Vancouver region has created the opportunity for over 90,000 units of new construction infill housing. Migration to China's first and second tier cities has topped the equivalent of 5 million households annually since 2000 resulting in a critical shortage of energy efficient, pre-manufactured small footprint wood frame housing," stated Mr. Michael Holloran, President and CEO. "Our joint venture combines the expertise of established players to target these markets and is designed to achieve $20 million in revenue within 3 years and $40 million within 5 years. This level of revenue growth requires less than a 1% share of the greater Vancouver infill market and 1.5 % of the First Nations home market without contribution from off shore opportunities."
About ILVC (www.intelligentliving.us): Intelligent Living Corp, utilizing green building practices, specializes in designing, supplying, installing, upgrading and servicing home and commercial automation systems including: energy use monitoring and control, security, occupancy monitoring and access control, lighting and HVAC control, and distributed audio/video systems. ILVC, a member of the Canadian Green Building Council, has supplied custom IT solutions since 1994 and automation solutions since 2003.
Safe Harbor Provision
This press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on the Company's current expectations as to future events. However, the forward-looking events and circumstances discussed in this press release might not occur, and actual results could differ materially from those anticipated or implied in the forward-looking statements. Risk factors include, lack of liquidity, availability of product, uncertainty concerning market acceptance of its designs, competition and other risk factors as outlined in the Company's SEC filings.
ILVC .Intelligent Living Joint Venture With First Nations Could Produce $40 Million in Revenues Within Five Years
Share
retweet
EmailPrint..Companies:INTELLIGENT LIVING.Related Quotes
Symbol Price Change
ILVC.OB 0.0125 0.00
{"s" : "ilvc.ob","k" : "a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00","o" : "","j" : ""} Press Release Source: Intelligent Living Corp. On Saturday December 4, 2010, 10:15 pm EST
VANCOUVER, BC--(Marketwire - 12/04/10) - Intelligent Living Corp. ("ILVC"), (OTC.BB:ILVC - News), a leading automation and technology solutions provider utilizing green building practices, is moving forward on a three part joint venture strategy that targets First Nations housing, small footprint new and re-developed housing within the Greater Vancouver market and export markets for small home technology. The joint venture strategy combines ILC's energy management and automation expertise with established First Nations domestic and offshore wood supply and small footprint home manufacturing to achieve target joint venture annual revenue of $40 million.
"Canadian Mortgage and Housing Corporation and National Aboriginal Housing Association have estimated the immediate sustainable demand for First Nations housing in British Columbia at over 20,000 units per year. Amendment of residential zoning with the greater Vancouver region has created the opportunity for over 90,000 units of new construction infill housing. Migration to China's first and second tier cities has topped the equivalent of 5 million households annually since 2000 resulting in a critical shortage of energy efficient, pre-manufactured small footprint wood frame housing," stated Mr. Michael Holloran, President and CEO. "Our joint venture combines the expertise of established players to target these markets and is designed to achieve $20 million in revenue within 3 years and $40 million within 5 years. This level of revenue growth requires less than a 1% share of the greater Vancouver infill market and 1.5 % of the First Nations home market without contribution from off shore opportunities."
About ILVC (www.intelligentliving.us): Intelligent Living Corp, utilizing green building practices, specializes in designing, supplying, installing, upgrading and servicing home and commercial automation systems including: energy use monitoring and control, security, occupancy monitoring and access control, lighting and HVAC control, and distributed audio/video systems. ILVC, a member of the Canadian Green Building Council, has supplied custom IT solutions since 1994 and automation solutions since 2003.
Safe Harbor Provision
This press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on the Company's current expectations as to future events. However, the forward-looking events and circumstances discussed in this press release might not occur, and actual results could differ materially from those anticipated or implied in the forward-looking statements. Risk factors include, lack of liquidity, availability of product, uncertainty concerning market acceptance of its designs, competition and other risk factors as outlined in the Company's SEC filings.
RLAB will most likely have a huge sell off considering the high volume and % gainer from yesterday
The Opportunity
Real American Brands, Inc. is a public company (trading under the symbol RLAB.PK.) whose focus is to identify and support products whose origins, design and character reflect our countries unique culture, heritage and way of life
RLAB owns Intellectual Property Rights for use on goods & services across a broad spectrum of wholesale retail and institutional product categories in both global and domestic markets.
RLAB owns trademarks for “Born & Bred in the USA” ; Lasso; Lariat; Riata (Spanish for lasso); Cosa Nostra – the apparel line; Green Blues; and Billy Martin’s – the western lifestyle brand and boutique.
Assets Owned
31 Year Old Western Lifestyle Brand: Billy Martin’s – all intellectual property rights owned by RLAB
“Billy Martin’s” boutique located at Trump Plaza 1034 Third Ave. in New York, NY
Licensing / Franchise Rights for Billy Martin’s name, including for new boutique worldwide
Exclusive representation agreement with national eco-friendly cleaning line for domestic & global expansion
American-made, environmentally friendly premium denim blue jeans concept named “Green Blues”
Line will carry two company-owned US Trademarks: “Green Blues” and “Born & Bred in the USA”
New fragrance products in development now, to be named “Lasso”, “Lariat” and “Riata” (Spanish for Lasso)
New non-emergency medical transport division in development now, named www.AssistedTransport.com
Domain name www.WeSaluteYou.Org to possible use to serve veterans and US service people / families
Domain names: wwwGreenBlues.Com and www.GreenBluesUSA.Com
Brands and Trademarks
RLAB owns the following brands and/or memorable US Trademarks
Born & Bred in the USA ~ trademark owned for use on any apparel and related product(s).
Billy Martin’s USA ~ the 29 year old western lifestyle company founded in NYC by Doug Newton
Lasso, Lariat, Riata (Spanish for lasso) – trademarks for cologne / fragrance product(s)
HBO-Deadwood Boot Collection ~ under license to Billy Martin’s from HBO Properties
One Pork Place ~ trademark owned for BBQ restaurant concept
Billy Martin’s
Billy Martin’s is a born-and-bred American company with a 31-year old brand name and history. We specialize in the sale of unique, upscale western-inspired apparel, boots, belts, buckles, accessories, jewelry, home decorations, furnishings, antiques, ephemera and Americana.
We stand for quality, value and the best American products and workmanship money can buy.
What Makes RLAB Different From its Competitors
RLAB is a publicly traded stock whose principal assets are valued US trademarks, including the mark “Born & Bred in the USA.”
Utilizing these trademarks are URL’s , RLAB is poised to enter high volume categories with raw, authentic American brands designed to celebrate and capitalize on each product’s own unique heritage and appeal
Specifically, the company will seek to establish a new, expanded market for its “Green Blues” eco-friendly denim brand, and designed to compete in the premium denim category but not at premium prices
RLAB is focusing on growing its existing Billy Martin’s western lifestyle brand via roll-out of new retail stores in select major markets in US and abroad
RLAB will expand its revenue base by aggressively seeking merger, acquisition and joint-venture opportunities with other American-originated businesses and brands
Ins summary, RLAB will seek to exploit its ownership of Intellectual property, to take advantage of the strong and growing appreciation for American-insired goods and services, especially ones that reflect our culture and American way of life…
The Management Team
Doug Newton is CEO of Real American Brands, Inc. and founder of its retail brand, Billy Martin’s. He has been the guiding spirit of the retail-based company since he and Billy founded it in New York City in 1978.
From 1976 to 1988, Doug headed Yankee One Managenet, Inc., clients included Roger Maris, Sparky Lyle, Whitey Ford, Phil Rizzuto, Randy Rasmussen, and Billy Martin.
For six years, Doug was Billy’s agent and business manager, negotiating his contacts with the NY Yankees, and Oakland A’s, and his commercials for Miller Lite Beer
Prior to Yankee One, he began his career at Benton & Bowles, Inc., managing accounts for General Foods(Post Cereals), Proctor & Gamble, Peter Paul Candy, Hasbro Toys, Norwich Pharmacal Co., Gillette (TRAC II) and the White House anti-inflation WIN campaign.
Find more info at http://stockbanana.com/Real_American_Brands_RLAB
The Opportunity
Real American Brands, Inc. is a public company (trading under the symbol RLAB.PK.) whose focus is to identify and support products whose origins, design and character reflect our countries unique culture, heritage and way of life
RLAB owns Intellectual Property Rights for use on goods & services across a broad spectrum of wholesale retail and institutional product categories in both global and domestic markets.
RLAB owns trademarks for “Born & Bred in the USA” ; Lasso; Lariat; Riata (Spanish for lasso); Cosa Nostra – the apparel line; Green Blues; and Billy Martin’s – the western lifestyle brand and boutique.
Assets Owned
31 Year Old Western Lifestyle Brand: Billy Martin’s – all intellectual property rights owned by RLAB
“Billy Martin’s” boutique located at Trump Plaza 1034 Third Ave. in New York, NY
Licensing / Franchise Rights for Billy Martin’s name, including for new boutique worldwide
Exclusive representation agreement with national eco-friendly cleaning line for domestic & global expansion
American-made, environmentally friendly premium denim blue jeans concept named “Green Blues”
Line will carry two company-owned US Trademarks: “Green Blues” and “Born & Bred in the USA”
New fragrance products in development now, to be named “Lasso”, “Lariat” and “Riata” (Spanish for Lasso)
New non-emergency medical transport division in development now, named www.AssistedTransport.com Domain name www.WeSaluteYou.Org to possible use to serve veterans and US service people / families
Domain names: wwwGreenBlues.Com and www.GreenBluesUSA.Com
Brands and Trademarks
RLAB owns the following brands and/or memorable US Trademarks
Born & Bred in the USA ~ trademark owned for use on any apparel and related product(s).
Billy Martin’s USA ~ the 29 year old western lifestyle company founded in NYC by Doug Newton
Lasso, Lariat, Riata (Spanish for lasso) – trademarks for cologne / fragrance product(s)
HBO-Deadwood Boot Collection ~ under license to Billy Martin’s from HBO Properties
One Pork Place ~ trademark owned for BBQ restaurant concept
Billy Martin’s
Billy Martin’s is a born-and-bred American company with a 31-year old brand name and history. We specialize in the sale of unique, upscale western-inspired apparel, boots, belts, buckles, accessories, jewelry, home decorations, furnishings, antiques, ephemera and Americana.
We stand for quality, value and the best American products and workmanship money can buy.
What Makes RLAB Different From its Competitors
RLAB is a publicly traded stock whose principal assets are valued US trademarks, including the mark “Born & Bred in the USA.”
Utilizing these trademarks are URL’s , RLAB is poised to enter high volume categories with raw, authentic American brands designed to celebrate and capitalize on each product’s own unique heritage and appeal
Specifically, the company will seek to establish a new, expanded market for its “Green Blues” eco-friendly denim brand, and designed to compete in the premium denim category but not at premium prices
RLAB is focusing on growing its existing Billy Martin’s western lifestyle brand via roll-out of new retail stores in select major markets in US and abroad
RLAB will expand its revenue base by aggressively seeking merger, acquisition and joint-venture opportunities with other American-originated businesses and brands
Ins summary, RLAB will seek to exploit its ownership of Intellectual property, to take advantage of the strong and growing appreciation for American-insired goods and services, especially ones that reflect our culture and American way of life…
The Management Team
Doug Newton is CEO of Real American Brands, Inc. and founder of its retail brand, Billy Martin’s. He has been the guiding spirit of the retail-based company since he and Billy founded it in New York City in 1978.
From 1976 to 1988, Doug headed Yankee One Managenet, Inc., clients included Roger Maris, Sparky Lyle, Whitey Ford, Phil Rizzuto, Randy Rasmussen, and Billy Martin.
For six years, Doug was Billy’s agent and business manager, negotiating his contacts with the NY Yankees, and Oakland A’s, and his commercials for Miller Lite Beer
Prior to Yankee One, he began his career at Benton & Bowles, Inc., managing accounts for General Foods(Post Cereals), Proctor & Gamble, Peter Paul Candy, Hasbro Toys, Norwich Pharmacal Co., Gillette (TRAC II) and the White House anti-inflation WIN campaign.
Products and Target Market: Real American Brands, Inc.
The company offers apparel, boots, belts, buckles, accessories, jewelry, home décor, furnishings, and antiques. It serves celebrities and VIP's from entertainment, arts, music, movies, sports, politics, and theatre.
The Opportunity
Real American Brands, Inc. is a public company (trading under the symbol RLAB.PK.) whose focus is to identify and support products whose origins, design and character reflect our countries unique culture, heritage and way of life
RLAB owns Intellectual Property Rights for use on goods & services across a broad spectrum of wholesale retail and institutional product categories in both global and domestic markets.
RLAB owns trademarks for “Born & Bred in the USA” ; Lasso; Lariat; Riata (Spanish for lasso); Cosa Nostra – the apparel line; Green Blues; and Billy Martin’s – the western lifestyle brand and boutique.
Assets Owned
31 Year Old Western Lifestyle Brand: Billy Martin’s – all intellectual property rights owned by RLAB
“Billy Martin’s” boutique located at Trump Plaza 1034 Third Ave. in New York, NY
Licensing / Franchise Rights for Billy Martin’s name, including for new boutique worldwide
Exclusive representation agreement with national eco-friendly cleaning line for domestic & global expansion
American-made, environmentally friendly premium denim blue jeans concept named “Green Blues”
Line will carry two company-owned US Trademarks: “Green Blues” and “Born & Bred in the USA”
New fragrance products in development now, to be named “Lasso”, “Lariat” and “Riata” (Spanish for Lasso)
New non-emergency medical transport division in development now, named www.AssistedTransport.com Domain name www.WeSaluteYou.Org to possible use to serve veterans and US service people / families
Domain names: wwwGreenBlues.Com and www.GreenBluesUSA.Com
Brands and Trademarks
RLAB owns the following brands and/or memorable US Trademarks
Born & Bred in the USA ~ trademark owned for use on any apparel and related product(s).
Billy Martin’s USA ~ the 29 year old western lifestyle company founded in NYC by Doug Newton
Lasso, Lariat, Riata (Spanish for lasso) – trademarks for cologne / fragrance product(s)
HBO-Deadwood Boot Collection ~ under license to Billy Martin’s from HBO Properties
One Pork Place ~ trademark owned for BBQ restaurant concept
Billy Martin’s
Billy Martin’s is a born-and-bred American company with a 31-year old brand name and history. We specialize in the sale of unique, upscale western-inspired apparel, boots, belts, buckles, accessories, jewelry, home decorations, furnishings, antiques, ephemera and Americana.
We stand for quality, value and the best American products and workmanship money can buy.
What Makes RLAB Different From its Competitors
RLAB is a publicly traded stock whose principal assets are valued US trademarks, including the mark “Born & Bred in the USA.”
Utilizing these trademarks are URL’s , RLAB is poised to enter high volume categories with raw, authentic American brands designed to celebrate and capitalize on each product’s own unique heritage and appeal
Specifically, the company will seek to establish a new, expanded market for its “Green Blues” eco-friendly denim brand, and designed to compete in the premium denim category but not at premium prices
RLAB is focusing on growing its existing Billy Martin’s western lifestyle brand via roll-out of new retail stores in select major markets in US and abroad
RLAB will expand its revenue base by aggressively seeking merger, acquisition and joint-venture opportunities with other American-originated businesses and brands
Ins summary, RLAB will seek to exploit its ownership of Intellectual property, to take advantage of the strong and growing appreciation for American-insired goods and services, especially ones that reflect our culture and American way of life…
The Management Team
Doug Newton is CEO of Real American Brands, Inc. and founder of its retail brand, Billy Martin’s. He has been the guiding spirit of the retail-based company since he and Billy founded it in New York City in 1978.
From 1976 to 1988, Doug headed Yankee One Managenet, Inc., clients included Roger Maris, Sparky Lyle, Whitey Ford, Phil Rizzuto, Randy Rasmussen, and Billy Martin.
For six years, Doug was Billy’s agent and business manager, negotiating his contacts with the NY Yankees, and Oakland A’s, and his commercials for Miller Lite Beer
Prior to Yankee One, he began his career at Benton & Bowles, Inc., managing accounts for General Foods(Post Cereals), Proctor & Gamble, Peter Paul Candy, Hasbro Toys, Norwich Pharmacal Co., Gillette (TRAC II) and the White House anti-inflation WIN campaign.
Products and Target Market: Real American Brands, Inc.
The company offers apparel, boots, belts, buckles, accessories, jewelry, home décor, furnishings, and antiques. It serves celebrities and VIP's from entertainment, arts, music, movies, sports, politics, and theatre.
The Opportunity
Real American Brands, Inc. is a public company (trading under the symbol RLAB.PK.) whose focus is to identify and support products whose origins, design and character reflect our countries unique culture, heritage and way of life
RLAB owns Intellectual Property Rights for use on goods & services across a broad spectrum of wholesale retail and institutional product categories in both global and domestic markets.
RLAB owns trademarks for “Born & Bred in the USA” ; Lasso; Lariat; Riata (Spanish for lasso); Cosa Nostra – the apparel line; Green Blues; and Billy Martin’s – the western lifestyle brand and boutique.
Assets Owned
31 Year Old Western Lifestyle Brand: Billy Martin’s – all intellectual property rights owned by RLAB
“Billy Martin’s” boutique located at Trump Plaza 1034 Third Ave. in New York, NY
Licensing / Franchise Rights for Billy Martin’s name, including for new boutique worldwide
Exclusive representation agreement with national eco-friendly cleaning line for domestic & global expansion
American-made, environmentally friendly premium denim blue jeans concept named “Green Blues”
Line will carry two company-owned US Trademarks: “Green Blues” and “Born & Bred in the USA”
New fragrance products in development now, to be named “Lasso”, “Lariat” and “Riata” (Spanish for Lasso)
New non-emergency medical transport division in development now, named www.AssistedTransport.com Domain name www.WeSaluteYou.Org to possible use to serve veterans and US service people / families
Domain names: wwwGreenBlues.Com and www.GreenBluesUSA.Com
Brands and Trademarks
RLAB owns the following brands and/or memorable US Trademarks
Born & Bred in the USA ~ trademark owned for use on any apparel and related product(s).
Billy Martin’s USA ~ the 29 year old western lifestyle company founded in NYC by Doug Newton
Lasso, Lariat, Riata (Spanish for lasso) – trademarks for cologne / fragrance product(s)
HBO-Deadwood Boot Collection ~ under license to Billy Martin’s from HBO Properties
One Pork Place ~ trademark owned for BBQ restaurant concept
Billy Martin’s
Billy Martin’s is a born-and-bred American company with a 31-year old brand name and history. We specialize in the sale of unique, upscale western-inspired apparel, boots, belts, buckles, accessories, jewelry, home decorations, furnishings, antiques, ephemera and Americana.
We stand for quality, value and the best American products and workmanship money can buy.
What Makes RLAB Different From its Competitors
RLAB is a publicly traded stock whose principal assets are valued US trademarks, including the mark “Born & Bred in the USA.”
Utilizing these trademarks are URL’s , RLAB is poised to enter high volume categories with raw, authentic American brands designed to celebrate and capitalize on each product’s own unique heritage and appeal
Specifically, the company will seek to establish a new, expanded market for its “Green Blues” eco-friendly denim brand, and designed to compete in the premium denim category but not at premium prices
RLAB is focusing on growing its existing Billy Martin’s western lifestyle brand via roll-out of new retail stores in select major markets in US and abroad
RLAB will expand its revenue base by aggressively seeking merger, acquisition and joint-venture opportunities with other American-originated businesses and brands
Ins summary, RLAB will seek to exploit its ownership of Intellectual property, to take advantage of the strong and growing appreciation for American-insired goods and services, especially ones that reflect our culture and American way of life…
The Management Team
Doug Newton is CEO of Real American Brands, Inc. and founder of its retail brand, Billy Martin’s. He has been the guiding spirit of the retail-based company since he and Billy founded it in New York City in 1978.
From 1976 to 1988, Doug headed Yankee One Managenet, Inc., clients included Roger Maris, Sparky Lyle, Whitey Ford, Phil Rizzuto, Randy Rasmussen, and Billy Martin.
For six years, Doug was Billy’s agent and business manager, negotiating his contacts with the NY Yankees, and Oakland A’s, and his commercials for Miller Lite Beer
Prior to Yankee One, he began his career at Benton & Bowles, Inc., managing accounts for General Foods(Post Cereals), Proctor & Gamble, Peter Paul Candy, Hasbro Toys, Norwich Pharmacal Co., Gillette (TRAC II) and the White House anti-inflation WIN campaign.
Products and Target Market: Real American Brands, Inc.
The company offers apparel, boots, belts, buckles, accessories, jewelry, home décor, furnishings, and antiques. It serves celebrities and VIP's from entertainment, arts, music, movies, sports, politics, and theatre.
MBYL news! MDC-Tracker Application Developed Exclusively For BlackBerry(TM) Internet Service Browsing, (BIS-B) Transport
.
Companies:MOBILE DATA CORP..Related Quotes
Symbol Price Change
MBYL.OB 0.18 0.00
{"s" : "mbyl.ob","k" : "a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00","o" : "","j" : ""} Press Release Source: Mobile Data Corp. On Tuesday November 23, 2010, 2:03 am EST
SAN JOSE, CA, Nov. 22 /PRNewswire/ - Mobile Data Corp. (OTCBB:MBYL.ob - News) announces that its software application, the MDC-Tracker, has been developed for initial, exclusive use on a wide range of BlackBerry™ SmartPhones and utilizes BlackBerry™ Internet Service Browsing (BIS-B) Transport.
The (BIS-B) Transport model allows software applications provided by Select Alliance Program development partners to establish connections from a BlackBerry™ device to the internet via a centrally hosted gateway within the (BIS-B) infrastructure. This gateway is based on Mobile Data Service (MDS) technology that is currently available for use in the BlackBerry™ Enterprise Server. Given that the gateway is centrally hosted and consistent across all networks, it provides Java applications with a consistent internet connection that is not dependent on the carrier's specific WAP or TCP gateway.
By developing applications specifically for use with (BIS-B), Mobile Data Corp can ensures that the delivery of information provided by the MDC-Tracker SmartPhone location finder is available for installation on all BlackBerry™ SmartPhone devices, worldwide.
The MDC-Tracker is a software application that tracks the location history of a SmartPhone over programmable specified time frames for business and human asset management reporting and accountability protocols.
Mobile Data Corp is a solutions provider for telecommunications and computer convergence.
Please contact us should you have any questions: info@mobiledatacorp.com
Further information about Mobile Data Corp., the "MDCTracker", and the " MDC-KidTracker" BlackBerry SmartPhone applications may be obtained from the company's website at www.mobiledatacorp.com.
Safe Harbor Statement
MBYL news MDC-Tracker Application Developed Exclusively For BlackBerry(TM) Internet Service Browsing, (BIS-B) Transport
.
Companies:MOBILE DATA CORP..Related Quotes
Symbol Price Change
MBYL.OB 0.18 0.00
{"s" : "mbyl.ob","k" : "a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00","o" : "","j" : ""} Press Release Source: Mobile Data Corp. On Tuesday November 23, 2010, 2:03 am EST
SAN JOSE, CA, Nov. 22 /PRNewswire/ - Mobile Data Corp. (OTCBB:MBYL.ob - News) announces that its software application, the MDC-Tracker, has been developed for initial, exclusive use on a wide range of BlackBerry™ SmartPhones and utilizes BlackBerry™ Internet Service Browsing (BIS-B) Transport.
The (BIS-B) Transport model allows software applications provided by Select Alliance Program development partners to establish connections from a BlackBerry™ device to the internet via a centrally hosted gateway within the (BIS-B) infrastructure. This gateway is based on Mobile Data Service (MDS) technology that is currently available for use in the BlackBerry™ Enterprise Server. Given that the gateway is centrally hosted and consistent across all networks, it provides Java applications with a consistent internet connection that is not dependent on the carrier's specific WAP or TCP gateway.
By developing applications specifically for use with (BIS-B), Mobile Data Corp can ensures that the delivery of information provided by the MDC-Tracker SmartPhone location finder is available for installation on all BlackBerry™ SmartPhone devices, worldwide.
The MDC-Tracker is a software application that tracks the location history of a SmartPhone over programmable specified time frames for business and human asset management reporting and accountability protocols.
Mobile Data Corp is a solutions provider for telecommunications and computer convergence.
Please contact us should you have any questions: info@mobiledatacorp.com
Further information about Mobile Data Corp., the "MDCTracker", and the " MDC-KidTracker" BlackBerry SmartPhone applications may be obtained from the company's website at www.mobiledatacorp.com.
Safe Harbor Statement
MBYL news! MDC-Tracker Application Developed Exclusively For BlackBerry(TM) Internet Service Browsing, (BIS-B) Transport
.
Companies:MOBILE DATA CORP..Related Quotes
Symbol Price Change
MBYL.OB 0.18 0.00
{"s" : "mbyl.ob","k" : "a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00","o" : "","j" : ""} Press Release Source: Mobile Data Corp. On Tuesday November 23, 2010, 2:03 am EST
SAN JOSE, CA, Nov. 22 /PRNewswire/ - Mobile Data Corp. (OTCBB:MBYL.ob - News) announces that its software application, the MDC-Tracker, has been developed for initial, exclusive use on a wide range of BlackBerry™ SmartPhones and utilizes BlackBerry™ Internet Service Browsing (BIS-B) Transport.
The (BIS-B) Transport model allows software applications provided by Select Alliance Program development partners to establish connections from a BlackBerry™ device to the internet via a centrally hosted gateway within the (BIS-B) infrastructure. This gateway is based on Mobile Data Service (MDS) technology that is currently available for use in the BlackBerry™ Enterprise Server. Given that the gateway is centrally hosted and consistent across all networks, it provides Java applications with a consistent internet connection that is not dependent on the carrier's specific WAP or TCP gateway.
By developing applications specifically for use with (BIS-B), Mobile Data Corp can ensures that the delivery of information provided by the MDC-Tracker SmartPhone location finder is available for installation on all BlackBerry™ SmartPhone devices, worldwide.
The MDC-Tracker is a software application that tracks the location history of a SmartPhone over programmable specified time frames for business and human asset management reporting and accountability protocols.
Mobile Data Corp is a solutions provider for telecommunications and computer convergence.
Please contact us should you have any questions: info@mobiledatacorp.com
Further information about Mobile Data Corp., the "MDCTracker", and the " MDC-KidTracker" BlackBerry SmartPhone applications may be obtained from the company's website at www.mobiledatacorp.com.
Safe Harbor Statement
SNSS Sunesis Issued Important U.S. Patent Covering Vosaroxin Clinical Formulation
.
Companies:Sunesis Pharmaceuticals Inc..Related Quotes
Symbol Price Change
SNSS 0.3150 0.0000
{"s" : "snss","k" : "a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00", "o" : "","j" : ""} Press Release Source: Sunesis Pharmaceuticals On Monday November 15, 2010, 7:30 am EST
SOUTH SAN FRANCISCO, CA--(Marketwire - 11/15/10) - Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS - News) today announced that the United States Patent and Trademark Office (USPTO) has granted U.S. Patent No. 7,829,577, claiming the Company's pharmaceutical compositions of lead drug candidate vosaroxin. This patent is scheduled to expire on March 14, 2025, and could be eligible for patent term extension beyond this date. Corresponding patent applications are pending in major markets throughout the world including Europe, Japan, Australia and Canada.
"This patent is an important new addition to our intellectual property estate, as it covers the formulation currently used in our clinical trials," stated Daniel Swisher, Chief Executive Officer of Sunesis. "Vosaroxin's extended patent life to 2025 increases not only the value of our AML franchise but also provides sufficient time for lifecycle evaluation of vosaroxin in other indications. We are pursuing a sophisticated and deliberate strategy to extend exclusive coverage in the vosaroxin patent estate beyond 2025. In addition to our granted patents, we have filed patent applications covering additional formulations, combination uses, dosing, manufacturing processes and composition of matter claims. We look forward to the successful prosecution of these patent applications in multiple territories around the world."
About Vosaroxin
Vosaroxin is a first-in-class anticancer quinolone derivative, or AQD, a class of compounds that has not been used previously for the treatment of cancer. Vosaroxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, G2 arrest and apoptosis. Vosaroxin is currently being evaluated in a fully enrolled single agent Phase 2 clinical trial (known as the REVEAL-1 trial) in previously untreated elderly AML patients and in a fully enrolled Phase 2 clinical trial combining vosaroxin with cytarabine for the treatment of patients with relapsed/refractory AML. A Phase 2 single agent clinical trial in platinum-resistant ovarian cancer has also been completed. Sunesis plans to initiate the VALOR trial, a multinational, randomized, double-blind, placebo-controlled, pivotal Phase 3 clinical trial of vosaroxin in combination with cytarabine in a relapsed/refractory AML patient population, in the fourth quarter of this year.
About Sunesis Pharmaceuticals
Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, vosaroxin, in multiple indications to improve the lives of people with cancer.
For additional information on Sunesis Pharmaceuticals, please visit Sunesis Pharmaceuticals - home.
This press release contains forward-looking statements, including without limitation statements related to the prosecution of patent applications and Sunesis' plans to initiate a pivotal Phase 3 clinical trial of vosaroxin in the fourth quarter of this year. Words such as "evaluate," "planned," "will," "look forward" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Sunesis' current expectations. Forward-looking statements involve risks and uncertainties. Sunesis' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include without limitation, risks related to Sunesis' need for additional funding to fully finance the planned vosaroxin pivotal trial, the risk that Sunesis' development activities for vosaroxin could be halted or significantly delayed for various reasons, the risk that Sunesis' clinical studies for vosaroxin may not demonstrate safety or efficacy or lead to regulatory approval, the risk that data to date and trends may not be predictive of future data or results, the risk that Sunesis' nonclinical studies and clinical studies may not satisfy the requirements of the FDA or other regulatory agencies, risks related to the conduct of Sunesis' clinical trials, risks related to the manufacturing of vosaroxin, and the risk that Sunesis' proprietary rights may not adequately protect vosaroxin. These and other risk factors are discussed under "Risk Factors" and elsewhere in Sunesis' Quarterly Report on Form 10-Q for the quarter ended September 30, 2010 and other filings with the Securities and Exchange Commission. Sunesis expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.
SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals, Inc.
SNSS Sunesis Issued Important U.S. Patent Covering Vosaroxin Clinical Formulation
.
Companies:Sunesis Pharmaceuticals Inc..Related Quotes
Symbol Price Change
SNSS 0.3150 0.0000
{"s" : "snss","k" : "a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00", "o" : "","j" : ""} Press Release Source: Sunesis Pharmaceuticals On Monday November 15, 2010, 7:30 am EST
SOUTH SAN FRANCISCO, CA--(Marketwire - 11/15/10) - Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS - News) today announced that the United States Patent and Trademark Office (USPTO) has granted U.S. Patent No. 7,829,577, claiming the Company's pharmaceutical compositions of lead drug candidate vosaroxin. This patent is scheduled to expire on March 14, 2025, and could be eligible for patent term extension beyond this date. Corresponding patent applications are pending in major markets throughout the world including Europe, Japan, Australia and Canada.
"This patent is an important new addition to our intellectual property estate, as it covers the formulation currently used in our clinical trials," stated Daniel Swisher, Chief Executive Officer of Sunesis. "Vosaroxin's extended patent life to 2025 increases not only the value of our AML franchise but also provides sufficient time for lifecycle evaluation of vosaroxin in other indications. We are pursuing a sophisticated and deliberate strategy to extend exclusive coverage in the vosaroxin patent estate beyond 2025. In addition to our granted patents, we have filed patent applications covering additional formulations, combination uses, dosing, manufacturing processes and composition of matter claims. We look forward to the successful prosecution of these patent applications in multiple territories around the world."
About Vosaroxin
Vosaroxin is a first-in-class anticancer quinolone derivative, or AQD, a class of compounds that has not been used previously for the treatment of cancer. Vosaroxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, G2 arrest and apoptosis. Vosaroxin is currently being evaluated in a fully enrolled single agent Phase 2 clinical trial (known as the REVEAL-1 trial) in previously untreated elderly AML patients and in a fully enrolled Phase 2 clinical trial combining vosaroxin with cytarabine for the treatment of patients with relapsed/refractory AML. A Phase 2 single agent clinical trial in platinum-resistant ovarian cancer has also been completed. Sunesis plans to initiate the VALOR trial, a multinational, randomized, double-blind, placebo-controlled, pivotal Phase 3 clinical trial of vosaroxin in combination with cytarabine in a relapsed/refractory AML patient population, in the fourth quarter of this year.
About Sunesis Pharmaceuticals
Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, vosaroxin, in multiple indications to improve the lives of people with cancer.
For additional information on Sunesis Pharmaceuticals, please visit Sunesis Pharmaceuticals - home.
This press release contains forward-looking statements, including without limitation statements related to the prosecution of patent applications and Sunesis' plans to initiate a pivotal Phase 3 clinical trial of vosaroxin in the fourth quarter of this year. Words such as "evaluate," "planned," "will," "look forward" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Sunesis' current expectations. Forward-looking statements involve risks and uncertainties. Sunesis' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include without limitation, risks related to Sunesis' need for additional funding to fully finance the planned vosaroxin pivotal trial, the risk that Sunesis' development activities for vosaroxin could be halted or significantly delayed for various reasons, the risk that Sunesis' clinical studies for vosaroxin may not demonstrate safety or efficacy or lead to regulatory approval, the risk that data to date and trends may not be predictive of future data or results, the risk that Sunesis' nonclinical studies and clinical studies may not satisfy the requirements of the FDA or other regulatory agencies, risks related to the conduct of Sunesis' clinical trials, risks related to the manufacturing of vosaroxin, and the risk that Sunesis' proprietary rights may not adequately protect vosaroxin. These and other risk factors are discussed under "Risk Factors" and elsewhere in Sunesis' Quarterly Report on Form 10-Q for the quarter ended September 30, 2010 and other filings with the Securities and Exchange Commission. Sunesis expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.
SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals, Inc.
SNSS Sunesis Issued Important U.S. Patent Covering Vosaroxin Clinical Formulation
.
Companies:Sunesis Pharmaceuticals Inc..Related Quotes
Symbol Price Change
SNSS 0.3150 0.0000
{"s" : "snss","k" : "a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00", "o" : "","j" : ""} Press Release Source: Sunesis Pharmaceuticals On Monday November 15, 2010, 7:30 am EST
SOUTH SAN FRANCISCO, CA--(Marketwire - 11/15/10) - Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS - News) today announced that the United States Patent and Trademark Office (USPTO) has granted U.S. Patent No. 7,829,577, claiming the Company's pharmaceutical compositions of lead drug candidate vosaroxin. This patent is scheduled to expire on March 14, 2025, and could be eligible for patent term extension beyond this date. Corresponding patent applications are pending in major markets throughout the world including Europe, Japan, Australia and Canada.
"This patent is an important new addition to our intellectual property estate, as it covers the formulation currently used in our clinical trials," stated Daniel Swisher, Chief Executive Officer of Sunesis. "Vosaroxin's extended patent life to 2025 increases not only the value of our AML franchise but also provides sufficient time for lifecycle evaluation of vosaroxin in other indications. We are pursuing a sophisticated and deliberate strategy to extend exclusive coverage in the vosaroxin patent estate beyond 2025. In addition to our granted patents, we have filed patent applications covering additional formulations, combination uses, dosing, manufacturing processes and composition of matter claims. We look forward to the successful prosecution of these patent applications in multiple territories around the world."
About Vosaroxin
Vosaroxin is a first-in-class anticancer quinolone derivative, or AQD, a class of compounds that has not been used previously for the treatment of cancer. Vosaroxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, G2 arrest and apoptosis. Vosaroxin is currently being evaluated in a fully enrolled single agent Phase 2 clinical trial (known as the REVEAL-1 trial) in previously untreated elderly AML patients and in a fully enrolled Phase 2 clinical trial combining vosaroxin with cytarabine for the treatment of patients with relapsed/refractory AML. A Phase 2 single agent clinical trial in platinum-resistant ovarian cancer has also been completed. Sunesis plans to initiate the VALOR trial, a multinational, randomized, double-blind, placebo-controlled, pivotal Phase 3 clinical trial of vosaroxin in combination with cytarabine in a relapsed/refractory AML patient population, in the fourth quarter of this year.
About Sunesis Pharmaceuticals
Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, vosaroxin, in multiple indications to improve the lives of people with cancer.
For additional information on Sunesis Pharmaceuticals, please visit Sunesis Pharmaceuticals - home.
This press release contains forward-looking statements, including without limitation statements related to the prosecution of patent applications and Sunesis' plans to initiate a pivotal Phase 3 clinical trial of vosaroxin in the fourth quarter of this year. Words such as "evaluate," "planned," "will," "look forward" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Sunesis' current expectations. Forward-looking statements involve risks and uncertainties. Sunesis' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include without limitation, risks related to Sunesis' need for additional funding to fully finance the planned vosaroxin pivotal trial, the risk that Sunesis' development activities for vosaroxin could be halted or significantly delayed for various reasons, the risk that Sunesis' clinical studies for vosaroxin may not demonstrate safety or efficacy or lead to regulatory approval, the risk that data to date and trends may not be predictive of future data or results, the risk that Sunesis' nonclinical studies and clinical studies may not satisfy the requirements of the FDA or other regulatory agencies, risks related to the conduct of Sunesis' clinical trials, risks related to the manufacturing of vosaroxin, and the risk that Sunesis' proprietary rights may not adequately protect vosaroxin. These and other risk factors are discussed under "Risk Factors" and elsewhere in Sunesis' Quarterly Report on Form 10-Q for the quarter ended September 30, 2010 and other filings with the Securities and Exchange Commission. Sunesis expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.
SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals, Inc.